Professor Phil Rowlings
(MBBS FRACP FRCPA MS, Director of Haematology, Conjoint Professor, Discipline Lead Haematology, School of Medicine & Public Health, University of Newcastle )

DepartmentHaematology
Research AreasGenetics, Health Services Research, Therapy and Treatment
Research TopicsLeukaemia/Lymphoma/Multiple Myeloma, Blood and bone marrow disorders
Research TypesClinical Trials, Laboratory Research, Survey / Observational Research, Dissemination / Implementation

Professor Philip Rowlings has over 20 years research experience in clinical trials of new treatments, biostatistical analyses of large datasets in blood and marrow transplant for leukaemia, multiple myeloma, lymphoma and other malignancies, as well as health resource utilisation.  In the last 10 years he has also been involved in autologous bone marrow stem cell therapy for heart disease and new methods of genetic analyses in multiple myeloma.

Publications / achievements

Professor Rowlings  is a member of Scientific Advisory Committees for the Center for International Blood and Marrow Transplant Research (CBMTR) based in Milwaukee and Mineanopolis USA, as well as the Asia Pacific Bone Marrow Transplant (APBMT) group based in Ngoya Japan.  He is current chair for the Autologous Bone Marrow Transplant Group of the NSW BMT Network, a division of the Agency for Clinical Innovation.

 Publications in order of frequency of citation may be found here:

http://scholar.google.com.au/scholar?hl=en&q=rowlings+p&btnG=&as_sdt=1%2C5

Getting to know you

When did you start doing research?

A biostatistical appetite was first whetted as a medical student in 1978, when I worked on a project looking at management of fractured neck of femur. However, when I became a doctor, haematology and bone marrow transplant became my passion.

What research projects are you currently working on?

The ability of blood and marrow transplantation to treat people with lymphoma involving the brain.New methods of genetic analyses to predict outcomes in multiple myeloma patients.Assessing whether patients with haematologic cancers take their medications as they're supposed to.The latest drug developments in treatment of multiple myeloma.

What research achievement are you most proud of?

Can I say two? One was the development of a new analytic method for assessing graft-versus-host disease (a complication of allogeneic bone marrow transplantation).  The other was collaborating with a cardiology colleague, and our team being the first in Australia, and one of the world pioneers in investigating autologous marrow stem cells in patients with heart disease.

What inspires you?

Being able to help people using my love for science.

What did you do before coming to work at Calvary Mater Newcastle?

I had worked for over six years in the USA both as a bone marrow transplant doctor and researcher.  I worked at SydneyHospital for a brief period after the USA, before joining the Mater in 2001.

What has helped you the most in your research at Calvary Mater Newcastle?

The wonderful collaboration of doctors, nurses, clinical trial and laboratory staff.

Who are your main collaborators at Calvary Mater Newcastle?

Michele Gambrill and the clinical trials staff, Dr Anoop Enjeti, Dr Hong Zhang, Geordie Zaunders in the HAPS laboratory.

What did you do before you became a researcher?

High school student! I've been involved in research throughout my medical student days and all my life as a doctor.

What made you decide to do research?

I love asking questions, measuring things and trying to work out how things work.  I was fortunate to have wonderful doctor-researcher mentors throughout my early medical career.

What was your first / worst / best / strangest / memorable /etc job in research?

Regular 5:30 am research meetings whilst at conferences in the USA, because of an extremely "driven" boss.

What do you do to relax?

Long adventure walks with my wife and learning French.

What is the craziest thing you have ever had to do "in the name of research"?

I gave 150 mls of my own bone marrow under local anaesthetic, for bone marrow stem cell experiments.

Last modified: